Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
South Korea's storage giants will release their financial reports next week, with AI storage demand driving higher profit expectations

South Korea's storage giants will release their financial reports next week, with AI storage demand driving higher profit expectations

智通财经智通财经2026/10/25 02:06
Show original
1. Samsung Electronics and SK Hynix will announce their third-quarter financial results next week. With strong demand for artificial intelligence memory chips, the market expects both companies to deliver robust performance. SK Hynix is scheduled to release its results on Wednesday, followed by Samsung Electronics on Thursday.2. Market estimates suggest that, driven by rising memory chip prices and sustained growth in demand for high-bandwidth memory (HBM) required by AI accelerators, the two companies’ combined operating profit may reach approximately 185 trillion Korean won, equivalent to 139.4 billion US dollars.3. Samsung Electronics previously forecast third-quarter revenue of 195 trillion Korean won and operating profit of 107.4 trillion Korean won in its earnings preview.4. Investors will focus on the progress of both chipmakers in supplying next-generation HBM4 chips for AI accelerators, such as NVIDIA’s Vera Rubin platform. Boosted by demand for traditional memory chips and high-end HBM products, SK Hynix is also expected to deliver an impressive financial report.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Amgen (AMGN.US) and AstraZeneca (AZN.US) combination therapy extends small cell lung cancer survival by eight months, reduces risk of death by 58%

Researchers combined Amgen's Imdelltra with AstraZeneca's Imfinzi and found that for patients with aggressive lung cancer whose tumors had already spread, this combination extended survival by about eight months compared to Imfinzi monotherapy. Small cell lung cancer is one of the cancer types with the worst prognosis.

智通财经•2026/10/25 02:56
Amgen (AMGN.US) and AstraZeneca (AZN.US) combination therapy extends small cell lung cancer survival by eight months, reduces risk of death by 58%